With more than 9000 employees at more than 20 sites, Catalent is a major player in the pharmaceutical industry. For more than 10 years, GELITA AG has treated the shareholding in R.P. Scherer as a purely financial investment and not as part of the core business. The joint venture between GELITA and R.P. Scherer, which was one of the first German-American joint ventures following the Second World War, now comes to an end after more than 60 years. GELITA will continue to provide the R.P. Scherer plant, located on the premises of GELITA AG, with gelatin, energy, steam, fresh water, etc.